The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Provided herein, inter alia, are methods and compounds for targeted autophagy.
本文提供了针对靶向自噬的方法和化合物。
INHIBITORS OF PAPILLOMA VIRUS
申请人:Yoakim Christiane
公开号:US20100041649A1
公开(公告)日:2010-02-18
A compound of formula (I) or its enantiomers or diastereoisomers thereof:
wherein: A, X, W, R
1
, Y; R
3
; and R
4
are as defined herein.
The compounds of the invention may be used as inhibitors of the papilloma virus E1-E2-DNA complex. The invention further provides a method of treating or preventing human papilloma virus infection.
A novel and efficient iodine-catalyzed one-pot reaction of aromatic amines, acetophenones, and elemental sulfur for the synthesis of 2-aryl benzothiazoles is described. The process involves sequential C-S and C-N bond formation followed by C(CO)-C bond cleavage from readily accessible starting materials. A wide range of functional groups is tolerated under oxidant and metal-free condition and moderate to good product yields are obtained. (C) 2018 Elsevier Ltd. All rights reserved.
LINKED DIIMIDAZOLE ANTIVIRALS
申请人:Or Yat Sun
公开号:US20100226882A1
公开(公告)日:2010-09-09
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:
which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.